ReLive Biotechnologies Limited
Jefferson Walker is an experienced sales and market leader in the healthcare biotechnology sector, currently serving as Director of Sales and Market Manager at ReLive Biotechnologies Limited since July 2025, where responsibility includes developing go-to-market strategies in sports medicine. Prior roles include National Accounts Director at Kerecis, focusing on advanced wound healing solutions; Vice President of Sales at ProgenaCare Global, overseeing global sales strategy for human keratin wound matrices; and various leadership positions at Integra LifeSciences, including managing substantial revenue from regenerative skin substitute sales across multiple states. Jefferson also held product management roles at Molnlycke Health Care, Cardinal Health, and DeRoyal, contributing to substantial product portfolios and new developments. An MBA in Marketing/Logistics was obtained from the University of Tennessee, Knoxville.
This person is not in any teams
This person is not in any offices
ReLive Biotechnologies Limited
ReLive is a pioneering global biotechnology company, founded in 2021 by a team of distinguished visionaries and accomplished experts in the fields of tissue engineering, regenerative medicine, and cell therapy. Backed by venture capital, along with the acquisition of CO.DON, ReLive brings together a diverse team of scientists, surgeons, managers and regulatory experts with extensive and direct experience in biotechnology, to collaborate and develop groundbreaking treatments that improve patient outcomes. Through our ongoing research and development efforts, we strive to make a lasting impact on the field of biotechnology and cell therapy and revolutionize the treatment of or theopoetic and reconstructive conditions.